Sign In
Get Started →
What are Thomas G. Kolaras’s favorite books?
Profile Image for Thomas G. Kolaras

Thomas G. Kolaras

Senior Vice President & General Manager, Medical Therapeutics at Endo Pharmaceuticals
SummaryAI Assisted Badge

Thomas Kolaras is a seasoned commercial leader with more than 25 years of extensive experience in the US and global bio-pharmaceutical industry.

Throughout his career, Thomas has demonstrated adeptness in leading and maneuvering complex bio-pharmaceutical businesses within specialty and retail markets, inclusive of intricate distribution channels.

His professional journey encompasses a diverse skill set ranging from marketing, sales, operations, market access, analytics, to business development across a broad spectrum of therapeutic categories and delivery systems, such as biologics, injectables, implants, intra-nasal, and oral therapies.

Thomas Kolaras excels in various facets of business management and strategy including marketing strategy, portfolio P&L management, team building, leadership, strategic planning, driving business results, life cycle management, long-term business planning, co-promotion leadership, global launch planning, specialty markets, market access, business development, and supply chain.

He holds a Bachelor of Science degree in Engineering from the University of Wisconsin-Madison.

Thomas has held key executive positions in renowned pharmaceutical companies such as Endo Pharmaceuticals, Otsuka America Pharmaceutical, Eisai Pharmaceuticals, and Novartis Consumer Health, showcasing his strategic acumen and leadership capabilities.

He has served in various roles including Vice President Marketing Specialty & Established Products, Vice President & General Manager Pain Business Unit, Vice-President Commercial Strategy & Patient Access, Vice-President and General Manager, Founder & President, Executive Director, Group Franchise Director, and Associate Director in these esteemed organizations.

Thomas Kolaras's extensive professional background and expertise make him a valuable asset in the bio-pharmaceutical industry, with a proven track record of driving business growth and success.

This public profile is provided courtesy of Clay. All information found here is in the public domain.